Transparency Reporting

For transparency purposes and pursuant to applicable law, Gilead will disclose transfers of value made to HCPs, HCOs and Patient Organizations based in Belgium on www.betransparent.be, including the name, amount and nature of the transfer of value and any other required information. Transfers of value granted in the framework of scientific research are disclosed on www.betransparent.be on an aggregated basis.

Inquiries about the disclosed transfers of value should be directed to [email protected].

For transparency purposes and in accordance with the applicable laws and/or ethics rules, Gilead will disclose transfers of value made to HCPs, HCOs and Patient Organizations based in Luxembourg on the appropriate platform, including the name, amount and nature of the transfer of value and any other required information.

The disclosure reports for Luxembourg may be consulted below:

Gilead Sciences Luxembourg EFPIA Report 2023 in English

Gilead Sciences Luxembourg EFPIA Report 2023 in French

Gilead Sciences Luxembourg Methodological Note 2023

Gilead Sciences Luxembourg EFPIA Report 2022 in English

Gilead Sciences Luxembourg EFPIA Report 2022 in French

Gilead Sciences Luxembourg Methodological Note 2022

Gilead Sciences Luxembourg EFPIA Report 2021 in English

Gilead Sciences Luxembourg EFPIA Report 2021 in French

Gilead Sciences Luxembourg Methodological Note 2021

Inquiries about the disclosed transfers of value should be directed to [email protected].